Verastem (VSTM) Cash from Investing Activities (2011 - 2026)
Verastem's quarterly Cash from Investing Activities came in at -$16.0 million in Q1 2026, down 1090.71% quarter-over-quarter from -$1.3 million in Q4 2025.
Verastem has reported Cash from Investing Activities for 16 years, with the latest figure at -$16.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$16.0 million; the trailing twelve-month figure through Mar 2026 stood at -$17.4 million (changed N/A YoY), and the FY2025 full-year result was -$9.6 million, down 116.05% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$16.0 million, down from -$1.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $31.0 million in Q1 2024, with the low at -$70.1 million in Q3 2023.
- Average Cash from Investing Activities over 5 years is $5.4 million, with a median of $12.7 million recorded in 2022.
- Year-over-year, Cash from Investing Activities surged 19634.85% in 2022 and slumped 1608.05% in 2023.
- Tracing VSTM's Cash from Investing Activities over 5 years: stood at $13.0 million in 2022, then dropped by 4.52% to $12.4 million in 2023, then jumped by 133.14% to $29.0 million in 2024, then plunged by 104.64% to -$1.3 million in 2025, then plunged by 1090.71% to -$16.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$16.0 million (Q1 2026), -$1.3 million (Q4 2025), and $29.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | -16.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.02 Mn |
| Mar 31, 2026 | -16.02 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Jun 30, 2024 | 28.99 Mn |
| Mar 31, 2024 | 30.98 Mn |
| Mar 31, 2024 | 30.98 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Sep 30, 2023 | -70.08 Mn |
| Sep 30, 2023 | -70.08 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | -804,000.00 |
| Mar 31, 2023 | -804,000.00 |
| Dec 31, 2022 | 13.03 Mn |
| Dec 31, 2022 | 13.03 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Sep 30, 2022 | 4.65 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Mar 31, 2022 | 19.26 Mn |
| Mar 31, 2022 | 19.26 Mn |
| Dec 31, 2021 | 66,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 10.00 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 2.39 Mn |
| Jun 30, 2021 | 2.39 Mn |
| Mar 31, 2021 | -12.37 Mn |
| Mar 31, 2021 | -12.37 Mn |
| Dec 31, 2020 | -79.38 Mn |
| Dec 31, 2020 | -79.38 Mn |
| Sep 30, 2020 | -6,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Mar 31, 2020 | 32.05 Mn |
| Mar 31, 2020 | 32.05 Mn |
| Dec 31, 2019 | 25.13 Mn |
| Dec 31, 2019 | 25.13 Mn |
| Sep 30, 2019 | 17.59 Mn |
| Sep 30, 2019 | 17.59 Mn |
| Jun 30, 2019 | 46.53 Mn |
| Jun 30, 2019 | 46.53 Mn |
| Mar 31, 2019 | 363,000.00 |
| Mar 31, 2019 | 363,000.00 |
| Dec 31, 2018 | -126.80 Mn |
| Dec 31, 2018 | -126.80 Mn |
| Sep 30, 2018 | -15.48 Mn |
| Sep 30, 2018 | -15.48 Mn |
| Jun 30, 2018 | -530,000.00 |
| Jun 30, 2018 | -530,000.00 |
| Mar 31, 2018 | 4.44 Mn |
| Mar 31, 2018 | 4.44 Mn |
| Dec 31, 2017 | 4.51 Mn |
| Dec 31, 2017 | 4.51 Mn |
| Sep 30, 2017 | 21.33 Mn |
| Sep 30, 2017 | 21.33 Mn |
| Jun 30, 2017 | 14.02 Mn |
| Jun 30, 2017 | 14.02 Mn |
| Mar 31, 2017 | 4.10 Mn |
| Mar 31, 2017 | 4.10 Mn |
| Dec 31, 2016 | 986,000.00 |
| Dec 31, 2016 | 986,000.00 |
| Sep 30, 2016 | 3.73 Mn |
| Sep 30, 2016 | 3.73 Mn |
| Jun 30, 2016 | 31.11 Mn |
| Jun 30, 2016 | 31.11 Mn |
| Mar 31, 2016 | 1.10 Mn |
| Mar 31, 2016 | 1.10 Mn |
| Dec 31, 2015 | 15.19 Mn |
| Dec 31, 2015 | 15.19 Mn |
| Sep 30, 2015 | -3.79 Mn |
| Sep 30, 2015 | -3.79 Mn |
| Jun 30, 2015 | 8.94 Mn |
| Jun 30, 2015 | 8.94 Mn |
| Mar 31, 2015 | -47.40 Mn |
| Mar 31, 2015 | -47.40 Mn |
| Dec 31, 2014 | 13.48 Mn |
| Dec 31, 2014 | 13.48 Mn |
| Sep 30, 2014 | 7.62 Mn |
| Sep 30, 2014 | 7.62 Mn |
| Jun 30, 2014 | 17.92 Mn |
| Jun 30, 2014 | 17.92 Mn |
| Mar 31, 2014 | 4.12 Mn |
| Mar 31, 2014 | 4.12 Mn |
| Dec 31, 2013 | 2.79 Mn |
| Dec 31, 2013 | 2.79 Mn |
| Sep 30, 2013 | -43.42 Mn |
| Sep 30, 2013 | -43.42 Mn |
| Jun 30, 2013 | -8.01 Mn |
| Jun 30, 2013 | -8.01 Mn |
| Mar 31, 2013 | 25.25 Mn |
| Mar 31, 2013 | 25.25 Mn |
| Dec 31, 2012 | 4.89 Mn |
| Dec 31, 2012 | 4.89 Mn |
| Sep 30, 2012 | 2.11 Mn |
| Sep 30, 2012 | 2.11 Mn |
| Jun 30, 2012 | -4.67 Mn |
| Jun 30, 2012 | -4.67 Mn |
| Mar 31, 2012 | -48.19 Mn |
| Mar 31, 2012 | -48.19 Mn |
| Dec 31, 2011 | -35.88 Mn |
| Dec 31, 2011 | -35.88 Mn |
| Sep 30, 2011 | -369,000.00 |
| Sep 30, 2011 | -369,000.00 |
| Jun 30, 2011 | -471,000.00 |
| Jun 30, 2011 | -471,000.00 |